CS logo
small CS logo
Groupe Hospitalier Bretagne Sud - Hôpital du Scorff

Lorient, France
Hospitalière à Lorient

About Groupe Hospitalier Bretagne Sud - Hôpital du Scorff


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Groupe Hospitalier Bretagne Sud - Hôpital du Scorff


During the past decade, Groupe Hospitalier Bretagne Sud - Hôpital du Scorff conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Groupe Hospitalier Bretagne Sud - Hôpital du Scorff" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Groupe Hospitalier Bretagne Sud - Hôpital du Scorff


According to Clinical.Site data, the most researched conditions in "Groupe Hospitalier Bretagne Sud - Hôpital du Scorff" are "Colorectal Cancer" (1 trials), "Epithelial Ovarian Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials), "Liver Cancer" (1 trials) and "Peritoneal Cancer" (1 trials). Many other conditions were trialed in "Groupe Hospitalier Bretagne Sud - Hôpital du Scorff" in a lesser frequency.

Clinical Trials Intervention Types at Groupe Hospitalier Bretagne Sud - Hôpital du Scorff


Most popular intervention types in "Groupe Hospitalier Bretagne Sud - Hôpital du Scorff" are "Drug" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "FOLFIRI regimen" (1 trials), "Placebo" (1 trials), "bevacizumab" (1 trials), "fluorouracil" (1 trials) and "irinotecan hydrochloride" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Groupe Hospitalier Bretagne Sud - Hôpital du Scorff


The vast majority of trials in "Groupe Hospitalier Bretagne Sud - Hôpital du Scorff" are 2 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Groupe Hospitalier Bretagne Sud - Hôpital du Scorff


Currently, there are NaN active trials in "Groupe Hospitalier Bretagne Sud - Hôpital du Scorff". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Groupe Hospitalier Bretagne Sud - Hôpital du Scorff, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Groupe Hospitalier Bretagne Sud - Hôpital du Scorff, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".